The effectiveness and safety of ofatumumab for the treatment of pemphigus vulgaris: a cohort study based on a registry database.
Ofatumumab combined with glucocorticoids demonstrated favorable effectiveness compared with GC group, without increasing severe adverse events.
Authors
- Xiaohong Li (ORCID: https://orcid.org/0009-0006-9612-3903)
- J. Wang (ORCID: https://orcid.org/0009-0004-2628-7713)
- Yiyi Wang (ORCID: https://orcid.org/0000-0003-2205-1362)
- Lu Jiang (ORCID: https://orcid.org/0000-0001-6003-7575)
- Xun Feng (ORCID: https://orcid.org/0009-0003-3486-8270)
- G.K. Kim
- Yue Xiao (ORCID: https://orcid.org/0000-0003-3013-9655)
- Mi Wang (ORCID: https://orcid.org/0009-0009-6851-5944)
- Xiwen Zhang
- Ping Tan (ORCID: https://orcid.org/0000-0002-4506-6973)
- Wei Li (ORCID: https://orcid.org/0000-0002-9585-2884)
- Jiyang Li (ORCID: https://orcid.org/0000-0002-6580-710X)
- Xingli Zhou (ORCID: https://orcid.org/0000-0001-7060-254X)
- Min Zou (ORCID: https://orcid.org/0009-0003-7116-5152)
- Mintong Wei
Institutions
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
Publication Details
- Journal
- PubMed
- Published
- 2025-01-01
- DOI
- https://doi.org/10.3389/fimmu.2025.1537334
- Primary Topic
- Autoimmune Bullous Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00